Medications for Influenza A Virus
16 results
Amantadine (amantadine)
(Amantadine)Coupler LLC
Usage: Amantadine hydrochloride tablets are indicated for prophylaxis and treatment of influenza A virus infection, and for managing Parkinson's disease and drug-induced extrapyramidal reactions. They support immune response following vaccination and are used in early-stage influenza treatment, though not a substitute for vaccination.
Amantadine hydrochloride (amantadine hydrochloride)
(amantadine hydrochloride)Graviti Pharmaceuticals Private Limited
Usage: Amantadine Hydrochloride Tablets are indicated for prophylaxis and treatment of influenza A virus infections, as well as for managing parkinsonism and drug-induced extrapyramidal reactions. They are not a substitute for vaccination and are less effective than other Parkinson's treatments.
Amantadine hydrochloride (amantadine hydrochloride)
(Amantadine Hydrochloride)Advagen Pharma Limited
Usage: Amantadine hydrochloride capsules are indicated for the prophylaxis and treatment of influenza A virus infections, as well as for the treatment of Parkinson's disease and drug-induced extrapyramidal reactions. It is not a substitute for vaccination and is less effective than levodopa for Parkinson's disease.
Amantadine hydrochloride (amantadine hydrochloride)
(Amantadine Hydrochloride)Bryant Ranch Prepack
Usage: Amantadine hydrochloride capsules are indicated for the prophylaxis and treatment of influenza A virus infections, as well as for treating Parkinson's disease, postencephalitic parkinsonism, and drug-induced extrapyramidal reactions. Early administration is recommended for effective treatment of influenza A.
Oseltamivir (oseltamivir)
(OSELTAMIVIR)Alembic Pharmaceuticals Inc.
Usage: Oseltamivir phosphate is indicated for the treatment of acute, uncomplicated influenza A and B in patients aged 2 weeks and older within 48 hours of symptom onset. It is also used for prophylaxis in individuals 1 year and older. Vaccination is recommended annually and resistance may impact effectiveness.
Oseltamivir phosphate (oseltamivir phosphate)
(Oseltamivir Phosphate)Neolpharma Inc
Usage: Oseltamivir phosphate is indicated for the treatment of acute, uncomplicated influenza A and B in patients aged 2 weeks and older, symptomatic for no more than 48 hours. It is also used for prophylaxis of influenza in individuals 1 year and older.
Oseltamivir phosphate (oseltamivir phosphate)
(Oseltamivir Phosphate)Asclemed USA, Inc.
Usage: Oseltamivir phosphate for oral suspension is indicated for treating acute, uncomplicated influenza A and B in patients 2 weeks and older within 48 hours of symptoms. It is also indicated for prophylaxis of influenza A and B in patients 1 year and older.
Oseltamivir phosphate (oseltamivir phosphate)
(Oseltamivir Phosphate)NuCare Pharmaceuticals,Inc.
Usage: Oseltamivir Phosphate is indicated for the treatment of acute, uncomplicated influenza A and B in patients aged 2 weeks and older within 48 hours of symptom onset, and for prophylaxis in patients aged 1 year and older. It is not a substitute for annual vaccinations.
Oseltamivir phosphate (oseltamivir phosphate)
(Oseltamivir phosphate)Novadoz Pharmaceuticals LLC
Usage: Oseltamivir phosphate capsules are indicated for the treatment of influenza A and B in patients aged 2 weeks and older, symptomatic for no more than 48 hours, and for prophylaxis in patients 1 year and older. It is not a substitute for annual influenza vaccination.
Oseltamivir phosphate (oseltamivir phosphate)
(Oseltamivir Phosphate)Lupin Pharmaceuticals Inc
Usage: Oseltamivir phosphate for oral suspension is indicated for treating acute influenza A and B in patients aged 2 weeks and older within 48 hours of symptom onset, and for prophylaxis in individuals 1 year and older. It is not a substitute for annual vaccination and has specific use limitations.